Triple negative breast cancer (TNBC) is a heterogeneous group of breast cancers
characterized by their lack of estrogen receptors, progesterone receptors, and the HER2 …

Simple Summary Triple-negative breast cancer (TNBC) is one of the most aggressive breast
cancer subtypes, largely due to heterogeneity and lack of treatment options. Due to absence …

Breast cancer (BC) is still the most common cancer among women worldwide. Amongst the
subtypes of BC, triple negative breast cancer (TNBC) is characterized by deficient …

Simple Summary Breast cancer emergencies have become a rapidly evolving field in
medicine during the last ten years. Carcinogenesis is a multiparametric process that …

Triple-negative breast cancer (TNBC) is one of the most heterogeneous diseases in solid
tumors and has limited therapeutic options. Due to the lack of appropriate targetable …

Breast cancer accounts for 25% of all types of cancer in women, and triple negative breast
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …

Triple-negative breast cancer (TNBC) is one of the most heterogeneous and aggressive
breast cancer subtypes with a high risk of death on recurrence. To date, TNBC is very …

Triple-negative breast cancer (TNBC) is a heterogeneous disease in which tumors are
defined by lack of expression of the estrogen receptor (ER), the progesterone receptor (PR) …

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is
conventionally characterized by the absence of estrogen receptor (ER), progesterone …

Triple-negative breast cancer (TNBC) is a highly malignant subtype of breast cancer (BC)
with vicious behaviors. TNBC is usually associated with relatively poor clinical outcomes …